SEC Form 4 · accession 0001203311-17-000046
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan G Drachman
Officer — CMO & EVP, R & D
Period of report
Aug 17, 2017
Accepted (ET)
Aug 18, 2017 · 8:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Aug 17, 2017 | A | 27,000 | $0.00 | A | 142,204 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F4 | $46.37 | Aug 17, 2017 | A | 2,156 | A | — | Aug 17, 2027 | Common Stock | 2,156 | 2,156 | D |
| Non-Qualified Stock Option (right to buy)F4 | $46.37 | Aug 17, 2017 | A | 65,344 | A | — | Aug 17, 2027 | Common Stock | 65,344 | 65,344 | D |
Explanation of responses
- F1These shares represent restricted stock units and will be settled in common stock upon vesting.
- F2Restricted stock units shall vest in full three (3) years from grant date.
- F3Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 116 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on July 31, 2017.
- F4Shares shall vest at a rate of 25% one year from grant date and monthly thereafter until all shares are fully vested four years form grant date.